All News

The upcoming National Association of Specialty Pharmacy annual meeting has unique offerings for attendees.

Large clinical trial shows no increase in adverse events from treatment with aspirin for heart failure.

Officials with the FDA are warning health care professionals and patients not to use any liquid product manufactured by PharmaTech LLC, Davie, Florida, due to possible Burkholderia cepacia contamination, according to a safety alert issued by the FDA.

Patients who previously had cancer but experience chronic non-cancer pain may seek treatment with naloxegol.

Naloxegol approved to treat opioid-induced constipation in patients with pain from previous treatment for cancer.

Housing Opportunities for Persons With AIDS program awarded $320.4 million to qualifying states and local jurisdictions.

Discontinuing statins found to increase the risk of recurrent stroke by 42%.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Abnormal protein deposits in the pancreas may lead to type 2 diabetes.

Study findings highlight the importance of community-based health interventions that target cancer prevention.

Repatha combined with statin therapy may reduce cardiovascular events.

Cyclosporiasis is an intestinal illness caused by a parasite and transmitted through consumption of contaminated food or water.

A study published in Pediatrics found no conclusive evidence to support the use of probiotics to prevent eczema and asthma in high-risk infants.

A Rhode Island independent pharmacy is the first in the country offering on-demand Lyme disease post-exposure prophylaxis.

Impairment in insulin and insulin growth factor seems to play a role in the development of Alzheimer's disease.

A review committee noted that this recommendation includes quadrivalent inactivated influenza vaccines.

The CDC has identified an increase in reported cases of cyclosporiasis, according to a health advisory issued by the CDC Health Alert Network.

Officials with the FDA have issued a safety alert warning against the use of “Balguti Kesaria (or Kesaria Balguti) Ayurvedic Medicine,” due to high levels of lead.

Federal regulations may help curb the high cost of prescription drugs.

The launch of a second Remicade biosimilar could open the floodgates to biosimilar competition in the specialty drug market.

Approval sought for vemurafenib (Zelboraf) to treat Erdheim-Chester disease with BRAF V600 mutation.

Diabetes, hypertension, and prehypertension could increase the risk of dementia regardless of race.

The anti-kickback statute makes it a felony to knowingly and willfully offer, pay, solicit, or receive any remuneration to induce a person (including a legal entity) to refer an individual for the furnishing or arranging for the furnishing of any Medicare-covered item or service.

FDA provides manufacturers with product-specific guidances for creating equivalent generic drugs.

Physical training further minimizes brain shrinkage in MS patients already receiving medication.

Infants born to overweight mothers have less developed lungs.

Compounded drug used after cataract surgery may threaten eyesight of patients.

Partner violence negatively impacts the ability of women with HIV to adhere to antiretrovirals.

Top news of the day from across the healthcare landscape.